RegulatoryOfficial

Paul-Ehrlich-Institut Highlights Vaccines and Antibodies in Fight Against Antimicrobial Resistance

🇩🇪 Paul-Ehrlich-Institut · Wed 18 Nov 2026

For World AMR Awareness Week, the German regulator outlines how vaccines curb antibiotic use and discusses EMA scientific advice on trials of vaccines and antibodies against resistant bacteria.

The Paul-Ehrlich-Institut (PEI), Germany's federal institute for vaccines and biomedical medicines, has published an awareness piece for World AMR Awareness Week, which runs from 18 to 24 November 2026. It sets out why vaccination matters in tackling antimicrobial resistance and presents recent research on clinical trials of vaccines and monoclonal antibodies aimed at resistant bacteria.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: Paul-Ehrlich-Institut ↗

Article written by VigiEye from the official source (Paul-Ehrlich-Institut). AI-assisted; check the source before acting.